Blood prime for cardiopulmonary bypass for Congenital Heart Disease
This trial evaluates if bloodless cardiac surgery has benefits for patients 3.5-12kg, such as reduced morbidity/mortality & shorter hospital stays.
- Congenital Heart Disease
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
Awards & Highlights
Find a site
Who is running the clinical trial?
Frequently Asked Questions
What is the size of this investigation’s participant pool?
"Indeed, clinicaltrials.gov attests to the active recruitment of 150 patients from one trial site since its posting on May 10th 2023 and subsequent editing on May 19th."
Is this clinical trial enrolling participants presently?
"Affirmative. Records on clinicaltrials.gov attest to this medical trial's current recruitment efforts, which began on May 10th 2023 and were last amended on May 19th of the same year. The study is searching for 150 patients from a single centre."